Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASCO
Filter by Topic
ASCO 2014 Highlights
ASCO 2014 – Colorectal and Head & Neck Cancer
ASCO 2014 – Immuno-Oncology
ASCO 2014 – Lung Cancer
ASCO 2015 - Lung Cancer
ASCO 2015 Highlights
ASCO 2016 – Lung Cancer
ASCO 2017 – Multiple Myeloma
ASCO 2018 Insights
ASCO 2019
ASCO 2020 Cholangiocarcinoma
ASCO Breast Cancer Symposium
ASCO Quality Care Symposium
ASCO’s 1st Quality Care Symposium
Blinatumomab in Relapsed/Refractory Acute Lymphoblastic Leukemia
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Adoptive T-Cell Therapy for Cervical Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Pembrolizumab (MK-3745) in Metastatic Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Concurrent Treatment of Advanced Melanoma with Ipilimumab and Nivolumab
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Ipilimumab for Initial Treatment of Metastatic Uveal Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Nivolumab Combined with Ipilimumab in Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Gefitinib Plus Carboplatin/Pemetrexed as First-Line Therapy of EGFR+ NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
First-Line Nivolumab Monotherapy in Advanced NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Results from the ARCHER 1009 Study: Dacomitinib Versus Erlotinib for Second-/Third-Line Therapy of Locally Advanced or Metastatic NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Results from PROFILE 1014: First-Line Crizotinib Versus Pemetrexed-Platinum in ALK+ NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Page 11 of 19
6
7
8
9
10
11
12
13
14
15
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma